Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Children identified for classroom-based math support show altered resting-state connectivity in parietal brain regions. | Sci Rep | 2025 | 40707592 | PubTator, text mining | PubMed |
| The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial. | Nat Med | 2025 | 40646322 | PubTator, text mining | PubMed |
| Clarifying the role of exosomal miR-137-3p in endometrial regeneration: Mechanistic gaps and future directions. | World J Stem Cells | 2025 | 40585957 | PubTator, text mining | PubMed |
| Quantification of the Impact of Structure Quality on Predicted Binding Free Energy Accuracy. | J Chem Inf Model | 2025 | 40583448 | PubTator, text mining | PubMed |
| Design and Semisynthesis of Ubiquitin Extension Probes for Structural Analysis of Cullin1-Mediated Substrate Polyubiquitination. | J Am Chem Soc | 2025 | 40561458 | PubTator, text mining | PubMed |
| Deciphering the transcriptional alterations in high grade serous ovarian cancer upon catalytic inactivation of protein kinase D. | Int J Biol Macromol | 2025 | 40516723 | PubTator, text mining | PubMed |
| Arkadia and Ark2C Promote Substrate Ubiquitylation with Multiple E2 Enzymes. | J Mol Biol | 2025 | 40451499 | PubTator, text mining | PubMed |
| The Emerging Role and Mechanism of E2/E3 Hybrid Enzyme UBE2O in Human Diseases. | Biomedicines | 2025 | 40426910 | PubTator, text mining | PubMed |
| Potential mechanisms of epigenetic regulation in diabetic retinopathy from the perspectives of multi-omics. | Diabetol Metab Syndr | 2025 | 40369608 | PubTator, text mining | PubMed |
| Design, optimization, and ADMET evaluation of S11a-0000168202: A promising LIMK1 inhibitor for gastric cancer treatment. | PLoS One | 2025 | 40367093 | PubTator, text mining | PubMed |
| HCM-Associated MuRF1 Variants Compromise Ubiquitylation and Are Predicted to Alter Protein Structure. | Int J Mol Sci | 2025 | 40332812 | PubTator, text mining | PubMed |
| The prediction of auditory consequences of own and observed actions: a brain decoding multivariate pattern study. | Cereb Cortex | 2025 | 40298443 | PubTator, text mining | PubMed |
| Design of Potent Telomerase Inhibitors using Ligand-based Approaches and Molecular Dynamics Simulations Studies. | Curr Drug Discov Technol | 2025 | 40289986 | PubTator, text mining | PubMed |
| Pathogenesis of Focal Segmental Glomerulosclerosis and Minimal Change Disease: Insights from Glomerular Proteomics. | Life (Basel) | 2025 | 40283082 | PubTator, text mining | PubMed |
| Identification of RING E3 pseudoligases in the TRIM protein family. | Nat Commun | 2025 | 40216791 | PubTator, text mining | PubMed |
| Uncovering critical transitions and molecule mechanisms in disease progressions using Gaussian graphical optimal transport. | Commun Biol | 2025 | 40189710 | PubTator, text mining | PubMed |
| Enzymatic protein fusions with 100% product yield. | Elife | 2025 | 40167156 | PubTator, text mining | PubMed |
| UBE2K Facilitates Erlotinib Resistance and Induces Epithelial Mesenchymal Transition in Osteosarcoma Cancer Stem-Like Cells via Activating the mTOR Signaling. | Pharmacology | 2025 | 40159320 | PubTator, text mining | PubMed |
| WITHDRAWN: Deciphering the transcriptional alterations in high grade serous ovarian cancer upon catalytic inactivation of protein kinase D. | Int J Biol Macromol | 2025 | 40057070 | PubTator, text mining | PubMed |
| Clozapine as an E3 Ligand for PROTAC Technology. | ACS Med Chem Lett | 2025 | 39967646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=4